NCT06637293

Brief Summary

The DAISEA-ECG project aims to improve the diagnosis of heart diseases in primary care through the DeepECG platform, which combines ECG-AI and ECHONeXT algorithms. This study uses a stepped wedge design, where each Family Medicine Group acts as its own control. The FMGs will gradually transition from the control period (without AI recommendations) to the intervention period (with AI recommendations activated) in a randomized sequence. The primary objective is to compare the sensitivity of family physicians in detecting cardiac pathologies, with and without the assistance of the DeepECG platform. Sensitivity is defined as the proportion of patients correctly referred to cardiology or for transthoracic echocardiography (TTE) among those who indeed required cardiovascular evaluation, as confirmed by an independent adjudication committee.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for not_applicable

Timeline
10mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress42%
Oct 2025Mar 2027

First Submitted

Initial submission to the registry

October 9, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
12 months until next milestone

Study Start

First participant enrolled

October 6, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

September 19, 2025

Status Verified

September 1, 2025

Enrollment Period

1.2 years

First QC Date

October 9, 2024

Last Update Submit

September 18, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • sensitivity of cardiology referrals

    Compare the sensitivity of cardiology referrals made by family physicians and nurse practitioners before and after the activation of AI-assisted diagnostics and recommendations from the DeepECG platform.

    18 months

Secondary Outcomes (1)

  • specificity, negative predictive value, and positive predictive value of cardiology referrals

    18 months

Study Arms (2)

No DeepECG plateform diagnosis & recommendations

NO INTERVENTION

DeepECG plateform diagnosis & recommendations

EXPERIMENTAL
Device: DeepECG plateform diagnosis & recommendations

Interventions

EchoNeXT\& ECG-AI algorithm

DeepECG plateform diagnosis & recommendations

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Family Physicians or Nurse Practitioners
  • Family physicians or nurse practitioners (NPs) practicing in one of the participating FMGs.
  • Family physicians who have given their free and informed consent. Patients
  • Adult patients (18 years or older). Patients without follow-up in cardiology or internal medicine for cardiovascular issues (arrhythmia, heart failure, myocardial infarction, atherosclerotic coronary artery disease, valvular heart disease) or those who had a negative investigation in the past with no additional follow-up.
  • ECG
  • Any 12-lead ECG performed with the MUSE GE 360 machine. ECG of adequate technical quality for interpretation (otherwise, it will be automatically rejected by the platform).

You may not qualify if:

  • Family Physicians or Nurse Practitioners
  • Family physicians practicing exclusively in pediatrics (patients under 18 years old).
  • Family physicians unable to follow the project guidelines.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Montreal Heart Institute

Montreal, Quebec, H1T1C8, Canada

Location

Related Links

Central Study Contacts

Marie-Gabrielle Lessard, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: stepped wedge randomization
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Interventional cardiologist

Study Record Dates

First Submitted

October 9, 2024

First Posted

October 15, 2024

Study Start

October 6, 2025

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

March 1, 2027

Last Updated

September 19, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations